| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 140, 193-205, Copyright © 1992 by American Society for Investigative Pathology
REGULAR ARTICLES |
IJ Edwards and WD Wagner
Department of Comparative Medicine, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina 27157-1040.
Cell surface proteoglycans of aortic smooth muscle cells of atherosclerosis-susceptible White Carneau (WC) and atherosclerosis- resistant Show Racer (SR) pigeons were compared to determine differences that may be involved in the greater proliferative properties of cultured WC cells. Using [35S]-sodium sulfate and [3H]- glucosamine as labeling precursors, chondroitin sulfate-proteoglycan (CS-PG) and heparin sulfate-proteoglycan (HS-PG) were identified as distinct molecules associated with the plasma membrane. Heparan sulfate- proteoglycan was reduced up to 50% in WC compared with SR cells, and, based on interaction with ion-exchange resin, had a lower charge density. These differences were not observed for the CS-PG from the two cell types. The mode of association of the cell surface PG with the plasma membrane was examined. Dissociation with 1 mol/l (molar) sodium chloride indicated that less than 10% of total cell surface PG were ironically associated with the cells. The remainder required detergent extraction, suggesting hydrophobic interactions with the plasma membrane. Both CS-PG and HS-PG displayed affinity for octyl sepharose and both were identified in isolated plasma membranes. These data present the first description of a hydrophobic CS-PG that is a significant and distinct cell-associated PG in arterial smooth muscle cells. The observation of decreased and structurally altered HS-PG in WC compared with SR cells is consistent with a potential growth regulatory function for this molecule.
This article has been cited by other articles:
![]() |
J. S. Refson, M. Schachter, M. K. Patel, A. D. Hughes, E. Munro, P. Chan, J. H. N. Wolfe, and P. S. Sever Vein Graft Stenosis and the Heparin Responsiveness of Human Vascular Smooth Muscle Cells Circulation, June 30, 1998; 97(25): 2506 - 2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Engelberg State-of the-Art Review : Endogenous Heparin Activity Deficiency and Atherosclerosis Clinical and Applied Thrombosis/Hemostasis, April 1, 1996; 2(2): 83 - 93. [PDF] |
||||
![]() |
I. J. Edwards, H. Xu, J. C. Obunike, I. J. Goldberg, and W. D. Wagner Differentiated Macrophages Synthesize a Heparan Sulfate Proteoglycan and an Oversulfated Chondroitin Sulfate Proteoglycan That Bind Lipoprotein Lipase Arterioscler. Thromb. Vasc. Biol., March 1, 1995; 15(3): 400 - 409. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |